Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis
Chemical Senses · 2023
DOI: 10.1093/chemse/bjad043 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Chemical Senses, 2023. Verfasst von Mackenzie E Hannum und 8 weiteren Autor:innen. Beteiligte Einrichtung: Monell Chemical Senses Center, 3500 Market St, Philadelphia PA 19104, USA. Hauptthemen laut MEDLINE: COVID-19, Ageusia, Olfaction Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS, NIDCD NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Chemosensory scientists have been skeptical that reports of COVID-19 taste loss are genuine, in part because before COVID-19 taste loss was rare and often confused with smell loss. Therefore, to establish the predicted prevalence rate of taste loss in COVID-19 patients, we conducted a systematic review and meta-analysis of 376 papers published in 2020–2021, with 235 meeting all inclusion criteria. Drawing on previous studies and guided by early meta-analyses, we explored how methodological differences (direct vs. self-report measures) may affect these estimates. We hypothesized that direct measures of taste are at least as sensitive as those obtained by self-report and that the preponderance of evidence confirms taste loss is a symptom of COVID-19. The meta-analysis showed that, among 138,015 COVID-19-positive patients, 36.62% reported taste dysfunction (95% confidence interval: 33.02%–40.39%), and the prevalence estimates were slightly but not significantly higher from studies using direct (n = 15) versus self-report (n = 220) methodologies (Q = 1.73, df = 1, P = 0.1889). Generally, males reported lower rates of taste loss than did females, and taste loss was highest among middle-aged adults. Thus, taste loss is likely a bona fide symptom of COVID-19, meriting further research into the most appropriate direct methods to measure it and its underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Monell Chemical Senses Center, 3500 Market St, Philadelphia PA 19104, USA.
- Department of Public Health, University of California Merced, Merced, CA 95348, USA.
- Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA.
- Division of Intramural Research, National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
ORCID-Profile: Cailu Lin, Danielle R Reed
Förderung
- NINR NIH HHS
- NIDCD NIH HHS
- Intramural NIH HHS
- NIH HHS
- NIH
- National Institute of Alcohol Abuse and Alcoholism
- National Institute of Nursing Research
- NIH Office of Workforce Diversity
Zitieren
APA
Hannum, M. E., Koch, R. J., Ramirez, V. A., Marks, S. S., Toskala, A. K., Herriman, R. D., Lin, C., Joseph, P. V., & Reed, D. R. (2023). Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis. Chemical Senses. https://doi.org/10.1093/chemse/bjad043
Vancouver
Hannum ME, Koch RJ, Ramirez VA, Marks SS, Toskala AK, Herriman RD, et al. Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis. Chemical Senses. 2023. doi:10.1093/chemse/bjad043
BibTeX
@article{Hannum2023,
author = {Hannum, Mackenzie E and Koch, Riley J and Ramirez, Vicente A and Marks, Sarah S and Toskala, Aurora K and Herriman, Riley D and Lin, Cailu and Joseph, Paule V and Reed, Danielle R},
title = {Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis},
journal = {Chemical Senses},
year = {2023},
doi = {10.1093/chemse/bjad043}
}
EUVIMED